Labquality EQAS by Aurevia - are launching a new pilot round for HPV-related head and neck cancer. This is a unique opportunity to participate in an EQA scheme using a new type of sample material for HPV-related head and neck cancer. The samples are cell derived paraffin sections for p16 immunohistological staining and paraffin scrolls for HPV nucleic acid detection. The participant can analyse and report the results of either one or both sample types. The distribution of this pilot round will be in April and registration is open until 28 March, 2025. Please find the registration link from the attached flyer.
(6800) Labquality_EQAS-by-Aurevia_Flyer_HPV_ 1.pdf (240 KB)
Labquality EQAS by Aurevia - are offering a new scheme for 2025. Please find details and registration link in the updated flyer for the Bordetella pertussis/parapertussis, nucleic acid detection scheme. The first round has been postponed to May 2025.
(5241) Labquality-EQAS-by-Aurevia-Bordetella-flyer-EN.pdf (116 KB)
Labquality EQAS by Aurevia - are also launching the first pilot programmes for 2025. Registration for these pilots is open, and will close on February 17, 2025. There is a limited number of samples for the pilot rounds available, and participants will be selected on a first-come, first-served basis. The rounds are free of charge for participants. The registration link for the pilots can be found in the attached flyers.
(2756) Labquality-EQAS-by-Aurevia-flyer_immunosupressants.pdf (136 KB)
(2708) Labquality-EQAS-by-Aurevia-flyer_EPO_TPO.pdf (136 KB)
(5305) Labquality-EQAS-by-Aurevia-flyer_BV.pdf (166 KB)
(6800) Labquality_EQAS-by-Aurevai_Flyer_HPV.pdf (143 KB)
(5043) Labquality_EQAS_by_Aurevia_Flyer_Gram stain.pdf (135 KB)